{"id":10751,"date":"2024-08-14T07:15:32","date_gmt":"2024-08-14T07:15:32","guid":{"rendered":"https:\/\/www.tender-lederberg.94-130-216-58.plesk.page\/1-afnet-ehra-konsensuskonferenz\/"},"modified":"2024-12-18T10:33:43","modified_gmt":"2024-12-18T10:33:43","slug":"1-afnet-ehra-konsensuskonferenz","status":"publish","type":"page","link":"https:\/\/www.af-net.eu\/en\/1-afnet-ehra-konsensuskonferenz\/","title":{"rendered":"1. afnet\/ehra konsensuskonferenz"},"content":{"rendered":"\n
\n
\n
January 22nd \u2013 23rd 2007<\/h5>

1. AFNET \/ EHRA\n
<\/strong>CONSENSUS CONFERENCE<\/h1>\n <\/div>\n <\/div>\n\n\n\n
<\/div>\n\n\n\n
\n
\n
\n
\"\"<\/figure>\n<\/div>\n\n\n\n
\n

The first conference in 2007 resulted in an expert consensus of outcome parameters for trials in atrial fibrillation patients. <\/strong> The scientists summarized a set of outcome parameters in seven relevant outcome domains, namely death, stroke, symptoms and quality of life, rhythm, left ventricular function, costs and emerging outcome parameters. Their recommendations influenced the current guidance on antiarrhythmic drugs of the European Medicines Agency.<\/p>\n\n\n\n

Scientific Committee:<\/strong>
Angelo Auricchio
G\u00fcnter Breithardt
Paulus Kirchhof
Silvia Priori  <\/p>\n\n\n\n

\n
\n
\n\tProgram<\/strong>
\n\t\t\"\"\n\t\t\"\"<\/a>\n<\/div>\n<\/div>\n\n\n\n
\n
\n\tPublication<\/strong>
\n\t\t\"\"\n\t\t\"\"<\/a>\n<\/div>\n<\/div>\n\n\n\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div><\/div>\n","protected":false},"excerpt":{"rendered":"

January 22nd \u2013 23rd 2007 1. AFNET \/ EHRA CONSENSUS CONFERENCE The first conference in 2007 resulted in an expert consensus of outcome parameters for trials in atrial fibrillation patients. The scientists summarized a set of outcome parameters in seven relevant outcome domains, namely death, stroke, symptoms and quality of life, rhythm, left ventricular function, … Read more<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"_uag_custom_page_level_css":"","iawp_total_views":4,"_vp_format_video_url":"","_vp_image_focal_point":[],"footnotes":""},"class_list":["post-10751","page","type-page","status-publish"],"acf":[],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"timeline-express":false,"timeline-express-thumbnail":false,"1536x1536":false,"2048x2048":false,"vp_sm":false,"vp_md":false,"vp_lg":false,"vp_xl":false,"vp_sm_popup":false,"vp_md_popup":false,"vp_xl_popup":false},"uagb_author_info":{"display_name":"admin","author_link":"https:\/\/www.af-net.eu\/en\/author\/cre8ors\/"},"uagb_comment_info":0,"uagb_excerpt":"January 22nd \u2013 23rd 2007 1. AFNET \/ EHRA CONSENSUS CONFERENCE The first conference in 2007 resulted in an expert consensus of outcome parameters for trials in atrial fibrillation patients. The scientists summarized a set of outcome parameters in seven relevant outcome domains, namely death, stroke, symptoms and quality of life, rhythm, left ventricular function,…","_links":{"self":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/pages\/10751","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/comments?post=10751"}],"version-history":[{"count":3,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/pages\/10751\/revisions"}],"predecessor-version":[{"id":13386,"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/pages\/10751\/revisions\/13386"}],"wp:attachment":[{"href":"https:\/\/www.af-net.eu\/en\/wp-json\/wp\/v2\/media?parent=10751"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}